Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial

Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label on the page updated to v3.5.4 from v3.5.3, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-05-17T08:47:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New site entry 'Research Site' added on 2026-05-07 to the study's list of participating locations, and a number of established centers were removed (e.g., The Angeles Clinic, UCLA Hematology Oncology, NYU Cancer Institute, Memorial Sloan Kettering, MD Anderson, START San Antonio, UW Carbone Cancer Center). These changes alter where patients can enroll and who is involved in the ARC-8 trial.
    Difference
    0.7%
    Check dated 2026-05-10T11:08:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new Nat Med publication citation for the trial has been added to Publications. The previous 'Online ahead of print' citation has been removed.
    Difference
    0.0%
    Check dated 2026-05-03T02:07:02.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The revision/version identifier in the page footer has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:44:00.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:38:56.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Added a Publications section with Quemliclustat and zimberelimab in metastatic pancreatic adenocarcinoma (Nat Med 2026) and PubMed notes. Updated Locations: removed Medical Oncology Associates (Spokane) and changed total locations from 14 to 13.
    Difference
    0.5%
    Check dated 2026-04-04T05:50:23.000Z thumbnail image

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.